Chest Pain Warning Signs: Emergency Causes, ECG, Troponin and 2025 ACS Guidance

Evidence and references reviewed: 10 November 2026.

New or changing chest discomfort needs careful assessment. The aim is to recognise time-sensitive disease early, not to decide at home whether pain sounds “typical.” This guide explains warning signs, assessment and the limits of common shortcuts.

Call for emergency help when a heart attack is possible

Warning symptoms include pressure, squeezing or heaviness in the chest; discomfort in either arm, the jaw, neck, back or upper abdomen; breathlessness; cold sweating; nausea; or lightheadedness. Some heart attacks begin mildly or with symptoms that come and go. Call local emergency services rather than waiting for pain to become severe or driving yourself.1

Women and men can both experience chest discomfort during a heart attack. Women may have additional nausea, breathlessness or unusual fatigue. The absence of a stereotypical crushing pain does not provide reassurance.1

Heart attack is not the only serious cause of chest pain

Possible cause Clues clinicians consider Safety message
Acute coronary syndrome (ACS) Pressure, tightness, radiation, breathlessness, nausea, diaphoresis or exertional symptoms. Emergency assessment with ECG and cardiac biomarkers; atypical descriptions do not exclude MI.
Pulmonary embolism Sudden shortness of breath, pleuritic pain, fast heart rate, unilateral leg swelling, recent immobility. May be life-threatening; needs structured emergency evaluation.
Aortic dissection Sudden severe chest or back pain, syncope, neurologic deficits, pulse or blood-pressure differences. Immediate emergency assessment; classic tearing pain is not universal.
Pneumothorax Sudden unilateral pain and breathlessness. Severe respiratory symptoms or hemodynamic compromise are emergencies.
Pericarditis Sharp pain varying with position or breathing, sometimes after viral illness. Needs assessment to distinguish from cardiac ischemia and other causes.
Reflux or chest-wall pain Burning after meals or reproducible tenderness. Potentially less dangerous, but the pattern alone does not prove benignity.

The 2021 AHA/ACC chest-pain guideline emphasizes describing symptoms as cardiac, possibly cardiac or noncardiac rather than relying on the term “atypical.” Clinical context, examination and testing determine what is most likely.2

Why the history alone is not enough

The AHA/ACC guideline treats new symptoms or a change in their pattern, intensity or duration as acute chest pain. Symptoms can be cardiac, possibly cardiac or noncardiac; “atypical” can misleadingly suggest that a presentation is harmless. A structured assessment is preferable to an arbitrary one-minute duration threshold.2

Relief after glyceryl trinitrate does not establish a cardiac diagnosis. NICE specifically advises against using that response diagnostically. A normal resting ECG also does not exclude an acute coronary syndrome. Persistent concern requires further assessment.3

What happens during assessment?

Clinicians assess the history, vital signs and ECG and use a validated clinical pathway. High-sensitivity cardiac troponin is the preferred biomarker; measurements are interpreted with symptom timing and, where indicated, serial results. One result should not be interpreted without knowing the assay and pathway. Risk tools need their required clinical and test inputs, not just a patient’s age and description of pain.2

An ECG should be obtained promptly, but obtaining or transmitting it must not delay emergency transfer. Changes over time can matter, so repeat assessment may be needed when symptoms continue or recur.3

2025 ACS guideline: ECG and troponin timing

The 2025 AHA/ACC acute coronary syndrome guideline recommends obtaining and interpreting a 12-lead ECG within 10 minutes of first medical contact when ACS is suspected. If the first tracing is nondiagnostic but concern remains high, serial ECGs can reveal evolving ischemic changes. A normal initial ECG does not rule out myocardial infarction.7

High-sensitivity cardiac troponin (hs-cTn) should be measured as soon as possible when ACS is suspected. When an initial value is nondiagnostic, the guideline recommends repeat testing after 1–2 hours for high-sensitivity assays, or 3–6 hours for conventional troponin assays, as indicated by the clinical pathway. These intervals refer to clinical testing after initial sampling, not a recommendation that a patient remain at home while waiting.7

Troponin elevation indicates myocardial injury but not always a type 1 heart attack. Myocarditis, severe sepsis, kidney disease, pulmonary embolism or severe physiological stress can also raise troponin; interpretation depends on symptoms, ECG, serial change and appropriate clinical criteria. Do not use consumer wearable ECG or smartwatch measurements as substitutes for emergency evaluation.

Medicines while waiting for help

Call first. Do not take aspirin and wait to see whether the pain improves. An emergency dispatcher or clinician may recommend aspirin after considering allergy and bleeding risk. Daily preventive aspirin is a separate decision and should not be started solely because an episode of chest discomfort occurred.4

If nitroglycerin has been prescribed, follow the personal emergency plan and tell the emergency team about recent medicines. Nitrates must not be combined with PDE5 inhibitors such as sildenafil or tadalafil, or with riociguat, because dangerous hypotension can occur. Do not borrow another person’s nitrate prescription.5

Treatment follows the confirmed clinical problem

For acute coronary syndromes, treatment may include antiplatelet therapy and revascularisation according to the clinical findings. The 2025 AHA/ACC guideline recommends high-intensity statins and generally uses aspirin plus an oral P2Y12 inhibitor for at least twelve months in patients without high bleeding risk. Bleeding risk and the need for anticoagulation can change the regimen. These are hospital-led treatment decisions, not a home checklist.6

Intermediate- or high-risk non-ST-elevation acute coronary syndrome generally warrants an invasive strategy during hospitalisation. A risk-score number alone does not identify an occluded artery or specify that every patient requires immediate catheterisation.6

How heart attack treatment differs from home first aid

For ST-elevation myocardial infarction (STEMI), emergency teams prioritize rapid reperfusion, usually primary percutaneous coronary intervention (PCI) when available in an appropriate timeframe. For non-ST-elevation ACS, antiplatelet and anticoagulant treatment, monitoring and timing of coronary angiography depend on risk and bleeding factors.6,7

Hospital medications must not be turned into unsupervised home protocols. Aspirin may be recommended by emergency professionals for suspected MI in a suitable person, but allergy, active bleeding and other conditions change that advice. Nitroglycerin may ease ischemic discomfort if properly prescribed but can cause dangerous hypotension, including after recent PDE5 inhibitor use; its ability to relieve pain does not establish the diagnosis.

Patients should keep a current list of medicines, drug allergies, previous cardiac procedures and onset times where possible, while prioritizing the emergency call. Do not drive yourself or delay transfer to find an old test result.

What does “low risk” mean?

Low risk is a conclusion reached through an appropriate clinical pathway. Some patients do not need urgent additional coronary testing after that assessment. This is different from reassuring someone on the basis of young age, a single symptom or a partially calculated score. Discharge should include a follow-up and return plan.2

Keep a record of when symptoms began, associated symptoms and medicines taken. Even when symptoms ease, communicate the full episode to the healthcare team; intermittent discomfort can still accompany a heart attack.1

Frequently asked questions

Can a heart attack feel like indigestion?

Yes. Some people experience upper-abdominal discomfort, nausea or fatigue rather than classic severe central pain. New or concerning symptoms need assessment.1

Does a normal ECG rule out heart attack?

No. Serial ECGs and troponin assessment may be needed.7

How quickly should an ECG be performed for suspected ACS?

The 2025 guideline recommends a 12-lead ECG within 10 minutes of first medical contact in appropriate settings.7

Can pain relief after nitroglycerin prove a heart cause?

No. It is not a reliable diagnostic test.3

Should everyone start daily aspirin for chest pain prevention?

No. Long-term antiplatelet therapy requires an individualized cardiovascular and bleeding-risk assessment.

References

  1. American Heart Association. Warning signs of a heart attack [Internet]. 2024 [cited 2026 Nov 9]. Available from: https://www.heart.org/health-topics/heart-attack/warning-signs-of-a-heart-attack
  2. American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2021 guideline for the evaluation and diagnosis of chest pain. J Am Coll Cardiol. 2021. doi:10.1016/j.jacc.2021.07.053. Available from: https://www.jacc.org/doi/full/10.1016/j.jacc.2021.07.053
  3. National Institute for Health and Care Excellence. Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis. CG95 [Internet]. [cited 2026 Nov 9]. Available from: https://www.nice.org.uk/guidance/cg95/chapter/recommendations
  4. American Heart Association. Aspirin and dual antiplatelet therapy [Internet]. [cited 2026 Nov 9]. Available from: https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/aspirin-and-heart-disease
  5. DailyMed. Nitrostat (nitroglycerin) tablets: prescribing information [Internet]. [cited 2026 Nov 9]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a52da75-d0af-4237-96c0-0b12adfa8636
  6. American Heart Association. Top things to know: 2025 guideline for acute coronary syndromes [Internet]. 2025 Feb 27 [cited 2026 Nov 9]. Available from: https://professional.heart.org/en/science-news/2025-guideline-for-the-management-of-patients-with-acute-coronary-syndromes/top-things-to-know
  7. Rao SV, O’Donoghue ML, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes. Circulation. 2025. doi:10.1161/CIR.0000000000001309.

⚠️ Medical Disclaimer

This article is intended for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.

The information provided here is based on current scientific literature and established pharmacological principles. However, medical knowledge evolves continuously, and individual patient responses to medications may vary. Healthcare professionals should always use their clinical judgment when applying this information to patient care.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *